We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Publishes Final Guidance for Small Entities Manufacturing HCT/Ps
FDA Publishes Final Guidance for Small Entities Manufacturing HCT/Ps
The FDA clarifies its regulatory requirements for small entity establishments that manufacture human cells, tissues, or cellular or tissue-based products (HCT/P), in a final guidance released today.